<?xml version="1.0" encoding="UTF-8"?>
<p id="Par38">Outcome data after DBS are available for around 30 
 <italic>GBA</italic>-PD patients, 60% of whom showed a favorable response, whereas 30% showed a poor response [
 <xref ref-type="bibr" rid="CR46">46</xref>]. However, sample sizes remain small and genetic testing does not yet provide added prognostic value over what can already be obtained through careful clinical assessment when the patient is evaluated for DBSÂ surgery [
 <xref ref-type="bibr" rid="CR81">81</xref>].
</p>
